Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations

scientific article

Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 382 Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 382 Warning: foreach() argument must be of type array|object, null given in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 383

Reverse relations

cites work (P2860)
Q388791381,25-Dihydroxyvitamin D as Monotherapy for XLH: Back to the Future?
Q30428653A Genetic Murine Model of Endolymphatic Hydrops: The Phex Mouse
Q39074268A Mutation in the Dmp1 Gene Alters Phosphate Responsiveness in Mice
Q35783146A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells
Q51308109A computationally identified compound antagonizes excess FGF-23 signaling in renal tubules and a mouse model of hypophosphatemia.
Q27690863A unified model for bone-renal mineral and energy metabolism
Q82680331Age-related stature and linear body segments in children with X-linked hypophosphatemic rickets
Q34632352Altered renal FGF23-mediated activity involving MAPK and Wnt: effects of the Hyp mutation
Q35869678Approach to the hypophosphatemic patient
Q36515176CYP24 inhibition as a therapeutic target in FGF23-mediated renal phosphate wasting disorders
Q48314203Cinacalcet as an alternative to phosphate therapy in X-linked hypophosphataemic rickets.
Q34262497Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status
Q36129867Conventional Therapy in Adults With XLH Improves Dental Manifestations, But Not Enthesopathy
Q37801814Disorders of phosphorus homeostasis
Q47180546Effects of growth hormone treatment on adult height in severely short children with X-linked hypophosphatemic rickets
Q48316515Evaluation of a New Fully Automated Assay for Plasma Intact FGF23.
Q35073296Evaluation of hypophosphatemia: lessons from patients with genetic disorders.
Q90624325FGF23 and Associated Disorders of Phosphate Wasting
Q64040255FGF23 and its role in X-linked hypophosphatemia-related morbidity
Q37806136Familial hypophosphatemia: an unusual presentation with low back ache, heel pain, and a limp in a young man, and literature review
Q55364455Fibroblast Growth Factor 2 and Its Receptors in Bone Biology and Disease.
Q36067879Fibroblast growth factor 23 and Inflammation in CKD
Q36360389Hereditary hypophosphatemia in Norway: a retrospective population-based study of genotypes, phenotypes, and treatment complications
Q56627579Hypophosphatemic rickets
Q34069793Hypophosphatemic rickets: revealing novel control points for phosphate homeostasis
Q38045788Hypophosphatemic rickets: unraveling the role of FGF23.
Q47760764Inhibition of FGFR Signaling Partially Rescues Hypophosphatemic Rickets in HMWFGF2 Tg Male Mice
Q37592511Iron and fibroblast growth factor 23 in X-linked hypophosphatemia
Q57736114Magnetic Resonance Imaging Features as Surrogate Markers of X-Linked Hypophosphatemic Rickets Activity
Q39720272Oncogenic osteomalacia illustrating the effect of fibroblast growth factor 23 on phosphate homeostasis
Q35860672Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23.
Q26860470Regulation and function of the FGF23/klotho endocrine pathways
Q27026805Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway
Q41119964Results of deformity correction in children with X-linked hereditary hypophosphatemic rickets by external fixation or combined technique
Q85036605Rickets
Q89703178Rickets
Q46294748Skeletal mineralization defects in adult hypophosphatasia--a clinical and histological analysis.
Q53695740The When, What & How of Measuring Vitamin D Metabolism in Clinical Medicine.
Q34221238The changing face of hypophosphatemic disorders in the FGF-23 era
Q36074718The chicken or the egg: PHEX, FGF23 and SIBLINGs unscrambled
Q36318290The consequences of chronic kidney disease on bone metabolism and growth in children
Q37648693Therapeutic management of hypophosphatemic rickets from infancy to adulthood.
Q34786125Three novel mutations in the PHEX gene in Chinese subjects with hypophosphatemic rickets extends genotypic variability.
Q41977160Three-year successful cinacalcet treatment of secondary hyperparathyroidism in a patient with x-linked dominant hypophosphatemic rickets: a case report
Q37107383Treatment of Hypophosphatemic Rickets with Phosphate and Active Vitamin D in Japan: A Questionnaire-based Survey
Q46711944Treatment of ear and bone disease in the Phex mouse mutant with dietary supplementation.
Q33952501Vitamin D status and bone and connective tissue turnover in brown bears (Ursus arctos) during hibernation and the active state
Q37056389What's new in FGF23 research?
Q39107200X-linked hypophosphatemia and growth.

Search more.